InvestorsHub Logo
Followers 2
Posts 1472
Boards Moderated 0
Alias Born 07/20/2016

Re: fbg0316 post# 75023

Saturday, 07/14/2018 1:24:57 PM

Saturday, July 14, 2018 1:24:57 PM

Post# of 108192
For some, I think the jury is still out on Ken as CEO. I see a CEO who is making better calls then his predecessors to ensure cash conservation and moving bigger market (hopefully) items to the front of the line. “With our announcement today of plans for a second IND submission for an ADXS-HOT construct in prostate cancer, we feel confident we can reach proof-of-concept for these off-the-shelf therapeutics in a relatively rapid and cost-effective manner.” I like that statement. We'll know soon enough how effective Ken is. If he can nail a couple of good, up-front cash deals, my hat will be off to him.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News